People channel feed – Endpoints News

People channel feed

Founders of poop-testing uBiome, reportedly on the run, charged by SEC with defrauding investors

5 years ago

Christopher Austin makes his return to industry, jumping ship from NIH over to CEO-partner role at Flagship

5 years ago

Drugmakers brace for a pricing fight as Xavier Becerra is confirmed as the next HHS secretary

5 years ago

Denied top job, Mike Nally exits chief marketing job at Merck as the big C-suite shakeup continues

5 years ago

A departing CMO pens a sad farewell as he heads back to the UK biopharma scene

5 years ago

After a roller coaster ride, Sage COO strikes out on his own to chart a new biotech path

5 years ago

Another bluebird exec jumps ship as questions swirl over gene therapies and imminent split

5 years ago

Fresh out of the bluebird bio oncology split, Joanne Smith-Farrell flies the coop to Be Bio and its B cell platform

5 years ago

BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines

5 years ago

Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies

5 years ago

Albert Bourla bagged $21M in year marked by generics spinoff, colossal R&D effort for Covid-19 vaccine

5 years ago

Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D

5 years ago

CFO departs Intercept as trickle becomes mass exodus from NASH biotech

5 years ago

With profits lagging, Emma Walmsley, Big Pharma's only woman CEO, may once again be its lowest paid

5 years ago

Eli Lilly promotes Edgardo Hernandez to head its manufacturing operations as 19-year vet O'Neill hits the exit

5 years ago

Exclusive: Former Intercept CMO lands new gig at Q32 Bio, two weeks after leaving the NASH biotech

5 years ago

Martin Shkreli faces another lawsuit, this time from insurer, alleging plans to create a monopoly for Daraprim

5 years ago

How does Paul Hudson's $13.5M comp package stack up against other CEOs? He's in the 'first quartile'

5 years ago

An Array co-founder re-emerges as CEO of a small academic spinout, looking to remake an old class of cancer drugs

5 years ago

With dust settled on activist attack, Laurence Cooper leaves Ziopharm to a new board

5 years ago

CMO Tal Zaks bids Moderna a surprise adieu as biotech projects $18.4B in revenue, plots post-Covid expansion

5 years ago

Biden is looking beyond Woodcock or Sharfstein for FDA commissioner — report

5 years ago

Japan's SoftBank plots billions in biotech investments in move that could keep the valuation flood rising — report

5 years ago

Stephen Hahn makes first post-FDA move, joining board of under-the-radar Philadelphia company

5 years ago

First page Previous page 60 61 626364 65 66 Next page Last page